InvestorsHub Logo
Followers 163
Posts 19648
Boards Moderated 2
Alias Born 12/09/2004

Re: FitzyP33 post# 458115

Thursday, 05/02/2024 2:03:17 PM

Thursday, May 02, 2024 2:03:17 PM

Post# of 459772
Toutain had been with the company since 2018.

Looks like he left for a significant increase in pay.

PDS Biotechnology Corporation has appointed Stephan F. Toutain as their new Chief Operations Officer, starting May 1, 2024. Bringing over three decades of pharmaceutical industry experience, Toutain has held significant roles at companies like Anavex Life Sciences and Interleukin Genetics. His compensation includes a $450,000 annual salary with potential for a 40% bonus, stock options, and severance benefits under certain conditions. The company announced his appointment in a press release on May 2, 2024.


Nunc est Bibendum

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News